001     142063
005     20240229105141.0
024 7 _ |2 doi
|a 10.3389/fped.2018.00024
024 7 _ |2 pmid
|a pmid:29497606
024 7 _ |2 pmc
|a pmc:PMC5819567
024 7 _ |a altmetric:33169283
|2 altmetric
037 _ _ |a DKFZ-2018-02293
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a König, Jens Christian
|b 0
245 _ _ |a Network for Early Onset Cystic Kidney Diseases-A Comprehensive Multidisciplinary Approach to Hereditary Cystic Kidney Diseases in Childhood.
260 _ _ |a Lausanne
|b Frontiers Media
|c 2018
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1549881753_32197
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |0 0
|2 EndNote
|a Journal Article
520 _ _ |a Hereditary cystic kidney diseases comprise a complex group of genetic disorders representing one of the most common causes of end-stage renal failure in childhood. The main representatives are autosomal recessive polycystic kidney disease, nephronophthisis, Bardet-Biedl syndrome, and hepatocyte nuclear factor-1beta nephropathy. Within the last years, genetic efforts have brought tremendous progress for the molecular understanding of hereditary cystic kidney diseases identifying more than 70 genes. Yet, genetic heterogeneity, phenotypic variability, a lack of reliable genotype-phenotype correlations and the absence of disease-specific biomarkers remain major challenges for physicians treating children with cystic kidney diseases. To tackle these challenges comprehensive scientific approaches are urgently needed that match the ongoing 'revolution' in genetics and molecular biology with an improved efficacy of clinical data collection. Network for early onset cystic kidney diseases (NEOCYST) is a multidisciplinary, multicenter collaborative combining a detailed collection of clinical data with translational scientific approaches addressing the genetic, molecular, and functional background of hereditary cystic kidney diseases. Consisting of seven work packages, including an international registry as well as a biobank, NEOCYST is not only dedicated to current scientific questions, but also provides a platform for longitudinal clinical surveillance and provides precious sources for high-quality research projects and future clinical trials. Funded by the German Federal Government, the NEOCYST collaborative started in February 2016. Here, we would like to introduce the rationale, design, and objectives of the network followed by a short overview on the current state of progress.
536 _ _ |0 G:(DE-HGF)POF3-317
|a 317 - Translational cancer research (POF3-317)
|c POF3-317
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Titieni, Andrea
|b 1
700 1 _ |a Konrad, Martin
|b 2
700 1 _ |a Consortium, NEOCYST
|b 3
|e Collaboration Author
700 1 _ |a Bergmann, C.
|b 4
700 1 _ |a Cetiner, M.
|b 5
700 1 _ |a Drube, J.
|b 6
700 1 _ |a Gimpel, C.
|b 7
700 1 _ |a Göbel, J.
|b 8
700 1 _ |a Haffner, D.
|b 9
700 1 _ |a Illig, T.
|b 10
700 1 _ |a Klopp, N.
|b 11
700 1 _ |a König, J.
|b 12
700 1 _ |a Konrad, M.
|b 13
700 1 _ |0 P:(DE-He78)e4ad7b4e684492de43cfcb12e5397439
|a Lablans, M.
|b 14
|u dkfz
700 1 _ |a Liebau, M. C.
|b 15
700 1 _ |a Lienkamp, S.
|b 16
700 1 _ |a Okorn, C.
|b 17
700 1 _ |a Omran, H.
|b 18
700 1 _ |a Pape, L.
|b 19
700 1 _ |a Pennekamp, P.
|b 20
700 1 _ |a Schaefer, F.
|b 21
700 1 _ |a Schermer, B.
|b 22
700 1 _ |a Storf, H.
|b 23
700 1 _ |a Titieni, A.
|b 24
700 1 _ |0 P:(DE-He78)28406352f67b7b6d43b303a4e955147a
|a Ückert, F.
|b 25
|u dkfz
700 1 _ |a Weber, S.
|b 26
700 1 _ |a Ziegler, W.
|b 27
773 _ _ |0 PERI:(DE-600)2711999-3
|a 10.3389/fped.2018.00024
|g Vol. 6, p. 24
|p 24
|t Frontiers in Pediatrics
|v 6
|x 2296-2360
|y 2018
909 C O |o oai:inrepo02.dkfz.de:142063
|p VDB
910 1 _ |0 I:(DE-588b)2036810-0
|6 P:(DE-He78)e4ad7b4e684492de43cfcb12e5397439
|a Deutsches Krebsforschungszentrum
|b 14
|k DKFZ
910 1 _ |0 I:(DE-588b)2036810-0
|6 P:(DE-He78)28406352f67b7b6d43b303a4e955147a
|a Deutsches Krebsforschungszentrum
|b 25
|k DKFZ
913 1 _ |0 G:(DE-HGF)POF3-317
|1 G:(DE-HGF)POF3-310
|2 G:(DE-HGF)POF3-300
|a DE-HGF
|l Krebsforschung
|v Translational cancer research
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b FRONT PEDIATR : 2017
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)0320
|2 StatID
|a DBCoverage
|b PubMed Central
915 _ _ |0 StatID:(DE-HGF)0501
|2 StatID
|a DBCoverage
|b DOAJ Seal
915 _ _ |0 StatID:(DE-HGF)0500
|2 StatID
|a DBCoverage
|b DOAJ
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b DOAJ : Blind peer review
915 _ _ |0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|a Creative Commons Attribution CC BY (No Version)
|b DOAJ
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
915 _ _ |0 StatID:(DE-HGF)0111
|2 StatID
|a WoS
|b Science Citation Index Expanded
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
915 _ _ |0 StatID:(DE-HGF)1110
|2 StatID
|a DBCoverage
|b Current Contents - Clinical Medicine
915 _ _ |0 StatID:(DE-HGF)9900
|2 StatID
|a IF < 5
920 1 _ |0 I:(DE-He78)G230-20160331
|k G230
|l Medizinische Informatik in der Translationalen Onkologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)G230-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21